Loading...
•
Sep 30, 2021
Axcelis Q3 2021 Earnings Report
Axcelis delivered strong third quarter financial performance driven by record implant systems revenue and solid gross margins.
Key Takeaways
Axcelis announced very strong third quarter financial performance, driven by record implant systems revenue and solid gross margins. The company is capitalizing on the strength of the mature and specialty markets with Purion product extensions.
Axcelis delivered very strong third quarter financial performance.
Record implant systems revenue was achieved.
Solid gross margins were reported.
The company is well positioned for long-term, sustainable growth.
Forward Guidance
For the fourth quarter ending December 31, 2021, Axcelis expects revenues to be approximately $190 million. Gross margin in the fourth quarter is expected to be approximately 41.5%. Fourth quarter operating profit is forecasted to be approximately $37 million with earnings per diluted share of approximately $0.84. The Company also expects to exceed $640 million in revenue for the full year 2021.
Positive Outlook
- Revenues to be approximately $190 million.
- Gross margin to be approximately 41.5%.
- Operating profit is forecasted to be approximately $37 million.
- Earnings per diluted share of approximately $0.84.
- Company also expects to exceed $640 million in revenue for the full year 2021.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...